Pub Date : 2025-09-12DOI: 10.1016/j.jctube.2025.100561
Zhengyu Shi , Juan Peng , Xiu Li , Xiaoyan Fu , Liping Zou , Qin Chen , Tao Huang , Yu Zhou , Hongmei Zhu , Yi Wang , Shenjie Tang , Guihui Wu
<div><h3>Background</h3><div>Rifampicin-resistant tuberculosis (RR-TB) is a major global public health challenge. Household close contacts (HHCs) of RR-TB patients face a high risk of <em>Mycobacterium tuberculosis</em> infection. Southwestern China carries a heavy RR-TB burden, yet research data on the infection status of this population remain scarce. This study aimed to evaluate the incidence of latent tuberculosis infection (LTBI) and active tuberculosis disease (TBD) and their associated factors among HHCs of RR-TB patients in this region through active screening, providing data support for optimizing regional RR-TB prevention and control strategies.</div></div><div><h3>Methods</h3><div>Using a cross-sectional design, HHCs of RR-TB patients diagnosed at Chengdu Public Health Clinical Medical Center from October 1, 2023, to March 30, 2025, were enrolled. Clinical data were collected via a self-designed questionnaire including gender, age, body mass index (BMI), relationship to index case, living environment, chronic comorbidities, medication history, and TBD-suspicious symptom screening. TBD screening used chest digital radiography (DR) or computed tomography (CT). Clinical data of index cases were extracted from the hospital information system (HIS), covering sputum acid-fast bacillus smear, sputum mycobacterial culture, sputum molecular testing for M. tuberculosis, fluoroquinolone resistance, extent of pulmonary lesions, and cavitation status. TB infection screening employed tuberculin skin test (TST), ESAT6-CFP10 fusion protein skin test (EC), or interferon-γ release assays (IGRA). Infection status was categorized as uninfected, LTBI, or TBD based on screening results, clinical symptoms, and imaging findings. Incidence rates of LTBI and TBD were calculated. Chi-square tests compared clinical characteristics across infection states. Multivariable logistic regression analyzed factors associated with LTBI and TBD (versus uninfected).</div></div><div><h3>Results</h3><div>264 HHCs from 197 RR-TB index cases were included: 113 males (42.8 %), 151 females (57.2 %), aged 3–78 years (mean 42.4 ± 15.1). Among 209 participants tested with TST: 117 (44.3 %) had induration diameter [0, 5) mm, 17 (6.4 %) [5, 10) mm, 30 (11.4 %) [10, 15) mm, 45 (17.1 %) ≥ 15 mm. Among 46 EC-tested: 29 (11.0 %) had [0, 5) mm, 17 (6.4 %) ≥ 5 mm. Among 9 IGRA-tested: 1 (0.4 %) negative, 8 (3.0 %) positive. After cluster-effect adjustment, LTBI incidence was 31.2 % (95 % confidence interval [CI]: 25.8–38.3), TBD incidence 9.9 % (95 % CI: 6.4–13.6). The proportion of spousal relationships to index cases was higher in LTBI/TBD groups than uninfected (P < 0.05). BMI < 18.5 kg/m<sup>2</sup> and positive TBD symptom screening were more frequent in TBD than uninfected/LTBI groups (P < 0.05). Pulmonary cavitation in index cases was more common in TBD contacts (P < 0.05). Multivariable analysis showed spousal relationship was an independent associated factor for LTBI (ad
耐利福平结核病(RR-TB)是一项重大的全球公共卫生挑战。RR-TB患者的家庭密切接触者(HHCs)面临结核分枝杆菌感染的高风险。中国西南地区是耐药结核病的重灾区,但有关该地区人群感染状况的研究数据仍然很少。本研究旨在通过主动筛查,评估该地区RR-TB患者hhc中潜伏性结核感染(LTBI)和活动性结核病(TBD)的发病率及其相关因素,为优化区域RR-TB防控策略提供数据支持。方法采用横断面设计,纳入2023年10月1日至2025年3月30日在成都市公共卫生临床医学中心诊断的RR-TB患者的hhc。通过自行设计的问卷收集临床资料,包括性别、年龄、体重指数(BMI)、与指标病例的关系、生活环境、慢性合并症、用药史、tbd可疑症状筛查等。TBD筛查采用胸部数字x线摄影(DR)或计算机断层扫描(CT)。从医院信息系统(HIS)中提取指标病例的临床资料,包括痰中抗酸杆菌涂片、痰中分枝杆菌培养、痰中结核分枝杆菌分子检测、氟喹诺酮类药物耐药性、肺部病变程度、空化情况等。结核感染筛查采用结核菌素皮肤试验(TST)、ESAT6-CFP10融合蛋白皮肤试验(EC)或干扰素γ释放试验(IGRA)。根据筛查结果、临床症状和影像学表现,感染状态分为未感染、LTBI或TBD。计算LTBI和TBD的发病率。卡方检验比较了不同感染状态的临床特征。多变量逻辑回归分析了与LTBI和TBD相关的因素(相对于未感染)。结果197例RR-TB指标病例共检出264例hhc:男性113例(42.8%),女性151例(57.2%),年龄3 ~ 78岁(平均42.4±15.1)。在209名接受TST测试的参与者中,117名(44.3%)患者的硬结直径为[0,5)mm, 17名(6.4%)[5,10]mm, 30名(11.4%)[10,15]mm, 45名(17.1%)≥15 mm。在46 EC-tested: 29(11.0%)[0, 5)毫米,17(6.4%)≥5毫米。9例igra检测:1例(0.4%)阴性,8例(3.0%)阳性。经聚类效应调整后,LTBI发生率为31.2%(95%可信区间[CI]: 25.8-38.3), TBD发生率为9.9% (95% CI: 6.4-13.6)。LTBI/TBD组配偶关系占指标病例的比例高于未感染组(P < 0.05)。BMI 18.5 kg/m2和TBD阳性症状筛查在TBD组比未感染/LTBI组更频繁(P < 0.05)。指标病例肺空化在TBD接触者中更为常见(P < 0.05)。多变量分析显示,配偶关系是LTBI的独立相关因素(校正优势比[aOR] = 2.102, 95% CI = 1.201 ~ 3.677; P = 0.009)。与TBD相关的因素包括:配偶关系(aOR = 3.949, 95% CI = 1.553 ~ 10.042; P = 0.004)、TBD阳性症状(aOR = 41.988, 95% CI = 4.270 ~ 412.886; P = 0.001)、指标病例肺空化(aOR = 2.881, 95% CI = 1.103 ~ 7.523; P = 0.031)。结论该地区RR-TB人群存在较高的LTBI和TBD发生率。配偶关系是LTBI和TBD的危险因素;TBD阳性症状和肺空化与TBD相关。建议积极筛查RR-TB HHCs并采取风险分层控制策略,以阻断传播链。
{"title":"Mycobacterium tuberculosis infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study","authors":"Zhengyu Shi , Juan Peng , Xiu Li , Xiaoyan Fu , Liping Zou , Qin Chen , Tao Huang , Yu Zhou , Hongmei Zhu , Yi Wang , Shenjie Tang , Guihui Wu","doi":"10.1016/j.jctube.2025.100561","DOIUrl":"10.1016/j.jctube.2025.100561","url":null,"abstract":"<div><h3>Background</h3><div>Rifampicin-resistant tuberculosis (RR-TB) is a major global public health challenge. Household close contacts (HHCs) of RR-TB patients face a high risk of <em>Mycobacterium tuberculosis</em> infection. Southwestern China carries a heavy RR-TB burden, yet research data on the infection status of this population remain scarce. This study aimed to evaluate the incidence of latent tuberculosis infection (LTBI) and active tuberculosis disease (TBD) and their associated factors among HHCs of RR-TB patients in this region through active screening, providing data support for optimizing regional RR-TB prevention and control strategies.</div></div><div><h3>Methods</h3><div>Using a cross-sectional design, HHCs of RR-TB patients diagnosed at Chengdu Public Health Clinical Medical Center from October 1, 2023, to March 30, 2025, were enrolled. Clinical data were collected via a self-designed questionnaire including gender, age, body mass index (BMI), relationship to index case, living environment, chronic comorbidities, medication history, and TBD-suspicious symptom screening. TBD screening used chest digital radiography (DR) or computed tomography (CT). Clinical data of index cases were extracted from the hospital information system (HIS), covering sputum acid-fast bacillus smear, sputum mycobacterial culture, sputum molecular testing for M. tuberculosis, fluoroquinolone resistance, extent of pulmonary lesions, and cavitation status. TB infection screening employed tuberculin skin test (TST), ESAT6-CFP10 fusion protein skin test (EC), or interferon-γ release assays (IGRA). Infection status was categorized as uninfected, LTBI, or TBD based on screening results, clinical symptoms, and imaging findings. Incidence rates of LTBI and TBD were calculated. Chi-square tests compared clinical characteristics across infection states. Multivariable logistic regression analyzed factors associated with LTBI and TBD (versus uninfected).</div></div><div><h3>Results</h3><div>264 HHCs from 197 RR-TB index cases were included: 113 males (42.8 %), 151 females (57.2 %), aged 3–78 years (mean 42.4 ± 15.1). Among 209 participants tested with TST: 117 (44.3 %) had induration diameter [0, 5) mm, 17 (6.4 %) [5, 10) mm, 30 (11.4 %) [10, 15) mm, 45 (17.1 %) ≥ 15 mm. Among 46 EC-tested: 29 (11.0 %) had [0, 5) mm, 17 (6.4 %) ≥ 5 mm. Among 9 IGRA-tested: 1 (0.4 %) negative, 8 (3.0 %) positive. After cluster-effect adjustment, LTBI incidence was 31.2 % (95 % confidence interval [CI]: 25.8–38.3), TBD incidence 9.9 % (95 % CI: 6.4–13.6). The proportion of spousal relationships to index cases was higher in LTBI/TBD groups than uninfected (P < 0.05). BMI < 18.5 kg/m<sup>2</sup> and positive TBD symptom screening were more frequent in TBD than uninfected/LTBI groups (P < 0.05). Pulmonary cavitation in index cases was more common in TBD contacts (P < 0.05). Multivariable analysis showed spousal relationship was an independent associated factor for LTBI (ad","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100561"},"PeriodicalIF":2.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145104935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-27DOI: 10.1016/j.jctube.2025.100560
Chadaporn N. Gordon , Nav La , Schawanya K. Rattanapitoon , Nathkapach K. Rattanapitoon
{"title":"Revisiting the therapeutic threshold in tuberculosis Care: Lessons from Southern Africa’s dual-method approach","authors":"Chadaporn N. Gordon , Nav La , Schawanya K. Rattanapitoon , Nathkapach K. Rattanapitoon","doi":"10.1016/j.jctube.2025.100560","DOIUrl":"10.1016/j.jctube.2025.100560","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100560"},"PeriodicalIF":2.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19DOI: 10.1016/j.jctube.2025.100559
Okumu Albert , Odeny Lazarus , Ochieng John Benjamin , Odhiambo Ben , Sitati Ruth , Tonui Joan , Ogoro Jeremiah , Wandiga Steve , Collins Ouma
Introduction
Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.
Method
Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.
Results
Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36–45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with M. intracellulare (44, 44 %).
Conclusions
High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.
{"title":"Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya","authors":"Okumu Albert , Odeny Lazarus , Ochieng John Benjamin , Odhiambo Ben , Sitati Ruth , Tonui Joan , Ogoro Jeremiah , Wandiga Steve , Collins Ouma","doi":"10.1016/j.jctube.2025.100559","DOIUrl":"10.1016/j.jctube.2025.100559","url":null,"abstract":"<div><h3>Introduction</h3><div>Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.</div></div><div><h3>Method</h3><div>Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.</div></div><div><h3>Results</h3><div>Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36–45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with <em>M. intracellulare</em> (44, 44 %).</div></div><div><h3>Conclusions</h3><div>High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100559"},"PeriodicalIF":2.0,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144879532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-13DOI: 10.1016/j.jctube.2025.100558
Roland Diel , Matthias Gröschel , Albert Nienhaus
Background
Only limited population-based data are available on the risk of latent tuberculosis infection (LTBI) in health care workers (HCWs).
Objective
To assess the long-term effects of protective measures of HCWs on LTBI risk in Hamburg, Germany.
Methods
Close contacts of smear-positive and smear-negative, but culture-confirmed, pulmonary TB index cases were prospectively enrolled from June 2005 to December 2017 and tested with the QuantiFERON TB (QFT) test approximately eight weeks after last exposure. Sociodemographic and clinical data were collected by trained healthcare personnel using a standardized questionnaire.
Contacts with known previous positive TST or IGRA results were excluded.
Results
After exclusion of prevalent TB cases and contact persons who had been tested positive in other settings, valid results were available for 937 index cases and 6980 close contacts (average per case 7.45; standard deviation (SD) ± 9.99; range 1–83). Of the contacts, 3459 (49.6 %) were males and 3520 (50.4 %) females. 771 contacts (11.05 %) belonged to 11 HCW subgroups, most of them (475, or 62.8 %) hospital or geriatric nurses. Foreign-born HCW did not differ significantly from non-HCW regarding origin from high-incidence countries.
By adjusting for confounders, logistic regression analysis confirmed household contact as strongest predictor for acquiring LTBI (OR 3.8, p < 0.001), followed by foreign-born status (OR 2.2, p < 0.001) and male gender (OR 1.28, p < 0.001). Contact with a smear-positive index case only slightly increased the risk of IGRA positivity, by 16 % (OR 1.16, p = 0.024). For each additional year of age, higher odds were found at 1.86 % (OR 1.019, p < 0.001] and for each additional hour of contact at approximately 0.11 % (OR 1.011, p < 0.001). BCG vaccination had no significant effect on IGRA test results (OR 0.95, p = 0.41).
Employment in healthcare overall was associated with a 26 % lower risk of IGRA positivity compared to non-HCWs (OR 0.74, p = 0.013); however, in a second adjusted model focusing on specific HCW subgroups, this risk reduction was statistically significant only for hospital and geriatric nurses, with no significant difference observed in other HCW subgroups.
Conclusion
Working in a health-care facility overall was associated with a lower LTBI risk compared to other risk factors. These findings suggest that protective measures might be particularly effective in hospital and geriatric nursing, while no risk reduction was evident for other HCW subgroups. Continued targeted protective measures remain important in high-risk care environments and support the relevance of recommendations issued (and last updated 2023) by the German Central Committee against Tuberculosis (DZK).
背景:关于卫生保健工作者(HCWs)潜伏性结核感染(LTBI)风险的基于人群的数据有限。目的评价德国汉堡地区医护人员防护措施对LTBI风险的长期影响。方法前瞻性纳入2005年6月至2017年12月期间痰检阳性和痰检阴性但经培养确诊的肺结核指数病例的密切接触者,并在最后一次接触后约8周进行QuantiFERON TB (QFT)检测。社会人口学和临床数据由训练有素的卫生保健人员使用标准化问卷收集。排除已知既往TST或IGRA阳性的接触者。结果在排除结核病流行病例和其他场所检测阳性的接触者后,对937例指数病例和6980例密切接触者(平均每例7.45例;标准偏差(SD)±9.99;范围1 - 83)。其中男性3459例(49.6%),女性3520例(50.4%)。771名接触者(11.05%)属于11个HCW亚组,其中大多数是医院或老年护士(475名,62.8%)。在高发病率国家的来源方面,外国出生的HCW与非HCW没有显著差异。通过调整混杂因素,逻辑回归分析证实家庭接触是获得LTBI的最强预测因子(OR 3.8, p <;0.001),其次是外国出生身份(OR 2.2, p <;0.001)和男性(OR 1.28, p <;0.001)。与涂片阳性指标病例接触仅略微增加IGRA阳性的风险,增加16% (OR 1.16, p = 0.024)。每增加1岁,患病几率增加1.86% (OR 1.019, p <;0.001]并且每增加一小时的接触,大约0.11% (OR 1.011, p <;0.001)。卡介苗接种对IGRA检测结果无显著影响(OR 0.95, p = 0.41)。总体而言,与非卫生保健工作者相比,卫生保健工作者IGRA阳性风险降低26% (OR 0.74, p = 0.013);然而,在针对特定HCW亚组的第二个调整模型中,这种风险降低仅在医院和老年护士中具有统计学意义,在其他HCW亚组中没有观察到显著差异。结论与其他危险因素相比,在卫生保健机构工作总体上与较低的LTBI风险相关。这些发现表明,保护措施可能在医院和老年护理中特别有效,而对其他HCW亚组没有明显的风险降低。在高风险护理环境中,继续采取有针对性的保护措施仍然很重要,并支持德国防治结核病中央委员会(DZK)发布的建议(最后一次更新于2023年)的相关性。
{"title":"Long-term occupational risk of latent tuberculosis infection in Hamburg, Germany: Findings from a 13-year prospective observational study","authors":"Roland Diel , Matthias Gröschel , Albert Nienhaus","doi":"10.1016/j.jctube.2025.100558","DOIUrl":"10.1016/j.jctube.2025.100558","url":null,"abstract":"<div><h3>Background</h3><div>Only limited population-based data are available on the risk of latent tuberculosis infection (LTBI) in health care workers (HCWs).</div></div><div><h3>Objective</h3><div>To assess the long-term effects of protective measures of HCWs on LTBI risk in Hamburg, Germany.</div></div><div><h3>Methods</h3><div>Close contacts of smear-positive and smear-negative, but culture-confirmed, pulmonary TB index cases were prospectively enrolled from June 2005 to December 2017 and tested with the QuantiFERON TB (QFT) test approximately eight weeks after last exposure<strong>.</strong> Sociodemographic and clinical data were collected by trained healthcare personnel using a standardized questionnaire.</div><div>Contacts with known previous positive TST or IGRA results were excluded.</div></div><div><h3>Results</h3><div>After exclusion of prevalent TB cases and contact persons who had been tested positive in other settings, valid results were available for 937 index cases and 6980 close contacts (average per case 7.45; standard deviation (SD) ± 9.99; range 1–83). Of the contacts, 3459 (49.6 %) were males and 3520 (50.4 %) females. 771 contacts (11.05 %) belonged to 11 HCW subgroups, most of them (475, or 62.8 %) hospital or geriatric nurses. Foreign-born HCW did not differ significantly from non-HCW regarding origin from high-incidence countries.</div><div>By adjusting for confounders, logistic regression analysis confirmed household contact as strongest predictor for acquiring LTBI (OR 3.8, p < 0.001), followed by foreign-born status (OR 2.2, p < 0.001) and male gender (OR 1.28, p < 0.001). Contact with a smear-positive index case only slightly increased the risk of IGRA positivity, by 16 % (OR 1.16, p = 0.024). For each additional year of age, higher odds were found at 1.86 % (OR 1.019, p < 0.001] and for each additional hour of contact at approximately 0.11 % (OR 1.011, p < 0.001). BCG vaccination had no significant effect on IGRA test results (OR 0.95, p = 0.41).</div><div>Employment in healthcare overall was associated with a 26 % lower risk of IGRA positivity compared to non-HCWs (OR 0.74, p = 0.013); however, in a second adjusted model focusing on specific HCW subgroups, this risk reduction was statistically significant only for hospital and geriatric nurses, with no significant difference observed in other HCW subgroups.</div></div><div><h3>Conclusion</h3><div>Working in a health-care facility overall was associated with a lower LTBI risk compared to other risk factors<del>.</del> These findings suggest that protective measures might be particularly effective in hospital and geriatric nursing, while no risk reduction was evident for other HCW subgroups. Continued targeted protective measures remain important in high-risk care environments and support the relevance of recommendations issued (and last updated 2023) by the German Central Committee against Tuberculosis (DZK).</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100558"},"PeriodicalIF":2.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144842539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-10DOI: 10.1016/j.jctube.2025.100556
Sergio Cotugno , Giacomo Guido , Francesco Di Gennaro , Francesco Cavallin , Mariantonietta Pisaturo , Lorenzo Onorato , Federica Zimmerhofer , Luca Pipitò , Giuseppina De Iaco , Giuseppe Bruno , Massimo Fasano , Agostina Pontarelli , Annarita Botta , Tiziana Iacovazzi , Rossana Lattanzio , Roberta Papagni , Elda De Vita , Alberto Zolezzi , Gianfranco Panico , Raffaella Libertone , Annalisa Saracino
Objective
Asymptomatic tuberculosis (ATB) represents a significant proportion of tuberculosis (TB) cases. This study aimed to compare ATB and symptomatic TB (STB) cases in terms of demographic and clinical characteristics, adverse events, hospital length of stay, and treatment outcomes.
Methods
This multicenter retrospective study included 510 microbiologically confirmed pulmonary TB patients across ten Italian hospitals between 2018 and 2023. STB cases presented with at least one symptom such as cough, fever, chest pain, hemoptysis, dyspnea, night sweats or weight loss. ATB cases presented with no symptoms. The endpoints included adverse events, length of hospital stay, and incompleteness of the treatment.
Results
ATB accounted for 36.4 % of cases (184/510). STB was significantly associated with diabetes (p = 0.03), hepatitis B/C infections (p < 0.0001), and history of TB (p = 0.01). Adjusting for clinically relevant confounders, STB was associated with higher occurrence of adverse events (odds ratio 2.04, 95 % confidence interval 1.31 to 3.23; p = 0.002), more severe adverse events (odds ratio 8.07, 95 % confidence interval 2.58 to 33.34; p = 0.001) and a 24 % increase in length of hospital stay (95 % confidence interval 7 % to 47 %; p = 0.005), but was not associated with incomplete treatment (odds ratio 0.79, 95 % confidence interval 0.47 to 1.32; p = 0.37).
Conclusions
STB is associated with a higher burden of adverse events. ATB poses challenges for TB elimination due to its asymptomatic nature.
{"title":"Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective study","authors":"Sergio Cotugno , Giacomo Guido , Francesco Di Gennaro , Francesco Cavallin , Mariantonietta Pisaturo , Lorenzo Onorato , Federica Zimmerhofer , Luca Pipitò , Giuseppina De Iaco , Giuseppe Bruno , Massimo Fasano , Agostina Pontarelli , Annarita Botta , Tiziana Iacovazzi , Rossana Lattanzio , Roberta Papagni , Elda De Vita , Alberto Zolezzi , Gianfranco Panico , Raffaella Libertone , Annalisa Saracino","doi":"10.1016/j.jctube.2025.100556","DOIUrl":"10.1016/j.jctube.2025.100556","url":null,"abstract":"<div><h3>Objective</h3><div>Asymptomatic tuberculosis (ATB) represents a significant proportion of tuberculosis (TB) cases. This study aimed to compare ATB and symptomatic TB (STB) cases in terms of demographic and clinical characteristics, adverse events, hospital length of stay, and treatment outcomes.</div></div><div><h3>Methods</h3><div>This multicenter retrospective study included 510 microbiologically confirmed pulmonary TB patients across ten Italian hospitals between 2018 and 2023. STB cases presented with at least one symptom such as cough, fever, chest pain, hemoptysis, dyspnea, night sweats or weight loss. ATB cases presented with no symptoms. The endpoints included adverse events, length of hospital stay, and incompleteness of the treatment.</div></div><div><h3>Results</h3><div>ATB accounted for 36.4 % of cases (184/510). STB was significantly associated with diabetes (p = 0.03), hepatitis B/C infections (p < 0.0001), and history of TB (p = 0.01). Adjusting for clinically relevant confounders, STB was associated with higher occurrence of adverse events (odds ratio 2.04, 95 % confidence interval 1.31 to 3.23; p = 0.002), more severe adverse events (odds ratio 8.07, 95 % confidence interval 2.58 to 33.34; p = 0.001) and a 24 % increase in length of hospital stay (95 % confidence interval 7 % to 47 %; p = 0.005), but was not associated with incomplete treatment (odds ratio 0.79, 95 % confidence interval 0.47 to 1.32; p = 0.37).</div></div><div><h3>Conclusions</h3><div>STB is associated with a higher burden of adverse events. ATB poses challenges for TB elimination due to its asymptomatic nature.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100556"},"PeriodicalIF":2.0,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144842512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.1016/j.jctube.2025.100543
Kristen A. Wendorf , Lisa Armitige
{"title":"Improving tuberculosis infection treatment completion among pregnant and postpartum women","authors":"Kristen A. Wendorf , Lisa Armitige","doi":"10.1016/j.jctube.2025.100543","DOIUrl":"10.1016/j.jctube.2025.100543","url":null,"abstract":"","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100543"},"PeriodicalIF":2.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-29DOI: 10.1016/j.jctube.2025.100555
Honghuan Song , Guoli Li , Zhuping Xu , Feixian Wang , Xiaoping Wang , Bing Dai , Xing Zhang , Jincheng Li , Yan Li , Limei Zhu
Background
Hospital-acquired Tuberculosis (TB) infections among healthcare workers (HCWs) and patients present a significant challenge due to the increased risk of TB infection within healthcare settings.
Methods
A standardized assessment tool was applied for the evaluation, which involved direct observation, document review, and interviews with facility heads. A baseline evaluation of TB infection control (TBIC) measures in TB outpatient and inpatient departments, as well as laboratories, was completed by January 2019. Based on the results, a comprehensive intervention package was implemented, incorporating a three-tiered hierarchy of controls: administrative control (AC), environmental control (EC), and respiratory protection (RP). Subsequent monitoring was conducted quarterly, with corrective actions accordingly. More than two years of follow-up data were collected, with the collaboration of local hospitals, the municipality Centers for Disease Control and Prevention (CDC), and the Jiangsu Provincial CDC, concluding on August 31, 2021.
Results
At baseline, the average implementation rates of AC, EC and RP were 57.3 %, 59.2 %, and 66.6 %, respectively. After the intervention, significant improvements were observed in key infection control measures. A triage process for cough patients was established, mechanical ventilation systems were installed, and the use of masks was improved. In addition, ultraviolet (UV) and upper-room ultraviolet germicidal irradiation (UVGI) systems were installed where required. As a result, the average implementation rates of AC, EC and RP significantly increased to 86.3 %, 87.4 %, and 98.4 % (P < 0.05), respectively. However, at the study’s conclusion, Suzhou Fifth People’s Hospital reported a lower AC implementation rate of 70.7 %, while Changzhou Third People’s Hospital had an EC implementation rate of 68.1 %. These discrepancies were primarily attributed to suboptimal architectural designs that hindered proper ventilation in the wards.
Conclusions
This study demonstrates that designated hospitals still face persistent gaps in tuberculosis infection control (TBIC). However, over the course of one and a half years of targeted and standardized interventions, substantial improvements in TBIC practices were achieved across most participating institutions. Despite the suboptimal availability of dedicated TB wards, strengthening TBIC measures remains crucial to reducing TB transmission among healthcare workers and non-TB patients. This approach is both practical and scalable, particularly in high-burden TB settings. Nevertheless, the long-term efficacy and sustainability of these TBIC practices warrant ongoing evaluation.
{"title":"Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China","authors":"Honghuan Song , Guoli Li , Zhuping Xu , Feixian Wang , Xiaoping Wang , Bing Dai , Xing Zhang , Jincheng Li , Yan Li , Limei Zhu","doi":"10.1016/j.jctube.2025.100555","DOIUrl":"10.1016/j.jctube.2025.100555","url":null,"abstract":"<div><h3>Background</h3><div>Hospital-acquired Tuberculosis (TB) infections among healthcare workers (HCWs) and patients present a significant challenge due to the increased risk of TB infection within healthcare settings.</div></div><div><h3>Methods</h3><div>A standardized assessment tool was applied for the evaluation, which involved direct observation, document review, and interviews with facility heads. A baseline evaluation of TB infection control (TBIC) measures in TB outpatient and inpatient departments, as well as laboratories, was completed by January 2019. Based on the results, a comprehensive intervention package was implemented, incorporating a three-tiered hierarchy of controls: administrative control (AC), environmental control (EC), and respiratory protection (RP). Subsequent monitoring was conducted quarterly, with corrective actions accordingly. More than two years of follow-up data were collected, with the collaboration of local hospitals, the municipality Centers for Disease Control and Prevention (CDC), and the Jiangsu Provincial CDC, concluding on August 31, 2021.</div></div><div><h3>Results</h3><div>At baseline, the average implementation rates of AC, EC and RP were 57.3 %, 59.2 %, and 66.6 %, respectively. After the intervention, significant improvements were observed in key infection control measures. A triage process for cough patients was established, mechanical ventilation systems were installed, and the use of masks was improved. In addition, ultraviolet (UV) and upper-room ultraviolet germicidal irradiation (UVGI) systems were installed where required. As a result, the average implementation rates of AC, EC and RP significantly increased to 86.3 %, 87.4 %, and 98.4 % (P < 0.05), respectively. However, at the study’s conclusion, Suzhou Fifth People’s Hospital reported a lower AC implementation rate of 70.7 %, while Changzhou Third People’s Hospital had an EC implementation rate of 68.1 %. These discrepancies were primarily attributed to suboptimal architectural designs that hindered proper ventilation in the wards.</div></div><div><h3>Conclusions</h3><div>This study demonstrates that designated hospitals still face persistent gaps in tuberculosis infection control (TBIC). However, over the course of one and a half years of targeted and standardized interventions, substantial improvements in TBIC practices were achieved across most participating institutions. Despite the suboptimal availability of dedicated TB wards, strengthening TBIC measures remains crucial to reducing TB transmission among healthcare workers and non-TB patients. This approach is both practical and scalable, particularly in high-burden TB settings. Nevertheless, the long-term efficacy and sustainability of these TBIC practices warrant ongoing evaluation.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100555"},"PeriodicalIF":2.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144758056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present a case series of six children who were infected with different species of Nontuberculous mycobacteria (NTM) and Mycobacterium riyadhense was the most prevalent isolate representing 50% of the total pathogens. Four of the reported cases were immunocompromised with disseminated NTM diseases and two were infected with M. avium, M. abscessus, and the other two infected with M. riyadhense. Most patients responded to medical therapy, except for the M. avium case, which was fatal despite combination therapy. Due to the presence of mycolic acid in the cell wall of NTM isolates, prolonged combination therapy is required for treatment, and in some cases, natural resistance may also emerge. Most of the patients reported in our study were immunocompetent. This suggests that NTM can infect children at various body sites regardless of immune status. We highlighted our experience in diagnosing and treating these patients, with special attention to M. riyadhense.
{"title":"Analysis of nontuberculous mycobacterial infections in Saudi children from a tertiary care hospital perspective","authors":"Norah Abukhalid , Nabeel Alzahrani , Khaled Alsager , Banan Alsowailmi , Amjad Albawardi","doi":"10.1016/j.jctube.2025.100554","DOIUrl":"10.1016/j.jctube.2025.100554","url":null,"abstract":"<div><div>We present a case series of six children who were infected with different species of<!--> <!-->Nontuberculous mycobacteria (NTM) and <em>Mycobacterium riyadhense</em> was the most prevalent isolate representing 50% of the total pathogens. Four of the reported cases were immunocompromised with disseminated NTM diseases and two were infected with <em>M. avium</em>, <em>M. abscessus</em>, and the other two infected with <em>M. riyadhense</em>. Most patients responded to medical therapy, except for the <em>M. avium</em> case, which was fatal despite combination therapy. Due to the presence of mycolic acid in the cell wall of NTM isolates, prolonged combination therapy is required for treatment, and in some cases, natural resistance may also emerge<del>.</del> Most of the patients reported in our study were immunocompetent. This suggests that NTM can infect children at various body sites regardless of immune status. We highlighted our experience in diagnosing and treating these patients, with special attention to <em>M. riyadhense</em>.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"41 ","pages":"Article 100554"},"PeriodicalIF":2.0,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144826945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-17DOI: 10.1016/j.jctube.2025.100553
Yiling Zhang , Gengmin Zhou , Hongli Wang , Qingwen Wang , Guofang Deng
Patients with systemic lupus erythematosus (SLE) have a higher incidence of tuberculosis (TB)infection compared to the general healthy population. The use of glucocorticoids and immunosuppressive agents for SLE management further elevates TB risk. This study aimed to evaluate the prevalence of latent tuberculosis infection (LTBI) in SLE patients and explore risk factors for progression to active TB (ATB) in those with concurrent SLE and LTBI. We conducted a retrospective analysis of SLE patients treated at the Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, between 2014 and 2023. During a five − year follow − up period, LTBI was detected in 122 patients (24.11%). Of these, 11 individuals (all from the subgroup of 108 patients who did not receive tuberculosis preventive treatment [TPT]) progressed to ATB. A comparative analysis between the 11 ATB cases and 111 non-progressing LTBI patients revealed significant differences: ATB cases showed higher cyclophosphamide (CTX) usage, elevated high-sensitivity C-reactive protein (hs-CRP) levels, and less frequent hydroxychloroquine (HCQ)administration. These findings underscore the need for regular monitoring during prolonged CTX therapy, especially in moderate-to-high TB burden regions, and highlight the potential protective role of HCQ.
{"title":"Retrospective analysis of systemic lupus erythematosus patients with latent tuberculosis infection: A 5-year follow-up study","authors":"Yiling Zhang , Gengmin Zhou , Hongli Wang , Qingwen Wang , Guofang Deng","doi":"10.1016/j.jctube.2025.100553","DOIUrl":"10.1016/j.jctube.2025.100553","url":null,"abstract":"<div><div>Patients with systemic lupus erythematosus (SLE) have a higher incidence of tuberculosis (TB)infection compared to the general healthy population. The use of glucocorticoids and immunosuppressive agents for SLE management further elevates TB risk. This study aimed to evaluate the prevalence of latent tuberculosis infection (LTBI) in SLE patients and explore risk factors for progression to active TB (ATB) in those with concurrent SLE and LTBI. We conducted a retrospective analysis of SLE patients treated at the Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, between 2014 and 2023. During a five − year follow − up period, LTBI was detected in 122 patients (24.11%). Of these, 11 individuals (all from the subgroup of 108 patients who did not receive tuberculosis preventive treatment [TPT]) progressed to ATB. A comparative analysis between the 11 ATB cases and 111 non-progressing LTBI patients revealed significant differences: ATB cases showed higher cyclophosphamide (CTX) usage, elevated high-sensitivity C-reactive protein (hs-CRP) levels, and less frequent hydroxychloroquine (HCQ)administration. These findings underscore the need for regular monitoring during prolonged CTX therapy, especially in moderate-to-high TB burden regions, and highlight the potential protective role of HCQ.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100553"},"PeriodicalIF":1.9,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144696731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-14DOI: 10.1016/j.jctube.2025.100552
Senjuti Kabir , Sabrina Choudhury , Mohammad Khaja Mafij Uddin , M.D. Fahim Ather , Syed Mohammad Mazidur Rahman , Pronab Kumar Modak , Mohammad Samsuddoha Sarker Shanchay , Tanjina Rahman , Shahriar Ahmed , Sayera Banu
Background
Performance of OMNIgene.SPUTUM (OM-S) for transporting sputum was evaluated.
Methods
This exploratory study was conducted during January-December 2019 at four near and one distant healthcare-facilities of Dhaka. Smear-positive pulmonary TB patients’ sputa were collected, divided into ‘OM-S untreated’ and ‘OM-S treated’ portions, and transported to testing laboratory, Dhaka, on same-day from near-sites, and through courier from distant-site for smear-microscopy, culture, and Xpert MTB/RIF (Xpert) testing. Subset of ‘OM-S treated’ sample was tested with Xpert without centrifugation. Test results of all portions were compared in between.
Results
Total 444 participants were enrolled (near-sites:198, distant-site: 246). All test results were comparable in both portions for near-sites. For distant-site, smear-microscopy’s positivity was reduced by 4.1 % in ‘OM-S treated’, Xpert showed 100 % concordance in both portions, and culture was higher in ‘OM-S treated’ than ‘OM-S untreated’ (92.3 % vs 89.4 %; p = 0.288). Primary contamination rate in ‘OM-S treated’ was lower than ‘OM-S untreated’ (2.0 % vs 9.8 %; p < 0.05). For all sites, median (IQR) time-to-culture positivity was 35 (28, 42) days in both portions. Xpert positivity was 99 % concordant in ‘OM-S treated’ regardless of centrifugation.
Conclusions
OM-S is safe for sputum transportation. OM-S mixed sputum can be tested with Xpert and culture. Further studies can validate findings and assess cost-effectiveness.
OMNIgene的背景性能。痰液(OM-S)用于痰液运输。方法本探索性研究于2019年1月至12月在达卡的四家近距离医疗机构和一家远距离医疗机构进行。收集痰液阳性肺结核患者的痰液,将其分为“未经OM-S治疗”和“OM-S治疗”两部分,并于当天从近地点和从远地点通过快递运送到达卡检测实验室,进行涂片显微镜、培养和Xpert MTB/RIF (Xpert)检测。“OM-S处理”样品的子集在不离心的情况下用Xpert进行测试。比较各部分的试验结果。结果共纳入受试者444例(近点198例,远点246例)。所有的测试结果在近地点的两个部分具有可比性。对于远处部位,“OM-S处理”的涂片显微镜阳性降低了4.1%,Xpert在两个部分显示100%的一致性,“OM-S处理”的培养高于“OM-S未处理”(92.3% vs 89.4%;p = 0.288)。“OM-S处理”组的初级污染率低于“OM-S未处理”组(2.0% vs 9.8%;p & lt;0.05)。对于所有站点,两个部分的中位(IQR)培养阳性时间为35(28,42)天。无论离心与否,“OM-S处理”的专家阳性结果一致性为99%。结论som - s用于痰液运输是安全的。OM-S混合痰液可以用Xpert法和培养法检测。进一步的研究可以验证研究结果并评估成本效益。
{"title":"OMNIgene.SPUTUM for transporting sputum in ambient temperature for tuberculosis testing: Bangladesh experience","authors":"Senjuti Kabir , Sabrina Choudhury , Mohammad Khaja Mafij Uddin , M.D. Fahim Ather , Syed Mohammad Mazidur Rahman , Pronab Kumar Modak , Mohammad Samsuddoha Sarker Shanchay , Tanjina Rahman , Shahriar Ahmed , Sayera Banu","doi":"10.1016/j.jctube.2025.100552","DOIUrl":"10.1016/j.jctube.2025.100552","url":null,"abstract":"<div><h3>Background</h3><div>Performance of OMNIgene.SPUTUM (OM-S) for transporting sputum was evaluated.</div></div><div><h3>Methods</h3><div>This exploratory study was conducted during January-December 2019 at four near and one distant healthcare-facilities of Dhaka. Smear-positive pulmonary TB patients’ sputa were collected, divided into ‘OM-S untreated’ and ‘OM-S treated’ portions, and transported to testing laboratory, Dhaka, on same-day from near-sites, and through courier from distant-site for smear-microscopy, culture, and Xpert MTB/RIF (Xpert) testing. Subset of ‘OM-S treated’ sample was tested with Xpert without centrifugation. Test results of all portions were compared in between.</div></div><div><h3>Results</h3><div>Total 444 participants were enrolled (near-sites:198, distant-site: 246). All test results were comparable in both portions for near-sites. For distant-site, smear-microscopy’s positivity was reduced by 4.1 % in ‘OM-S treated’, Xpert showed 100 % concordance in both portions, and culture was higher in ‘OM-S treated’ than ‘OM-S untreated’ (92.3 % vs 89.4 %; p = 0.288). Primary contamination rate in ‘OM-S treated’ was lower than ‘OM-S untreated’ (2.0 % vs 9.8 %; p < 0.05). For all sites, median (IQR) time-to-culture positivity was 35 (28, 42) days in both portions. Xpert positivity was 99 % concordant in ‘OM-S treated’ regardless of centrifugation.</div></div><div><h3>Conclusions</h3><div>OM-S is safe for sputum transportation. OM-S mixed sputum can be tested with Xpert and culture. Further studies can validate findings and assess cost-effectiveness.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100552"},"PeriodicalIF":1.9,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144634174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}